3 курс / Общая хирургия и оперативная хирургия / Зейналов_Э_К_Тактика_хирургического_лечения_больных_с_ИБС_и_рецидивирующей

43.Abbott JD, Voss MR, Nakamura M et al. Unrestricted use of drugeluting stents compared with bare-metal stents in routine clinical practice: findings from the National Heart, Lung, and Blood Institute Dynamic Registry.// J. Am. Coll. Cardiol.- 2007.-Vol. 50(21).-P.,2029–2036.

44.Access to Cardiac Care in the UK. A Report on Recent Trends, Variations in Access and Future Need. www. C1D_Access_to_Cardiac_Care_in_the_UK_- _UK_by_Country_&_English_SHA_-_FINAL2.pdf.

45.Aggarwal A. Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting./ Schneider DJ, Terrien EF, Terrien Jr CM, Sobel BE, Dauerman HL.// Am J Cardiol. – 2003. – Vol. 91. – P.1346-1349.

46.Aggarwal A. Comparison of effects of abciximab versus eptifibatide on C-reactive protein, interleukin-6, and interleukin-1 receptor antagonist after coronary arterial stenting./ Schneider DJ, Terrien EF, Terrien Jr CM, Sobel BE, Dauerman HL.// Am J Cardiol. – 2003. – Vol.91. – P.1346-1349.

47.Airoldi F, Colombo A, Morici N, Latib A, Cosgrave J, Buellesfeld L, et al. Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment.// Circulation. – 200. – Vol.

116.– P.745-754.

48.Aksoy R., Şenocak M., Güngör Arslan D., Şensöz Y., Özdemir F.,Balcı A. Y., Sargın M.. Kısa U., Yekeler İ. Is Coronary Bypass Operation More

Risky in Patients Undergoing Previous Percutaneous Coronary Intervention?//

Koşuyolu Heart Journal. – 2014. – Vol.17(1). – P.30-36

49.Almagor M. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. / Keren A, Banai S.// Am Heart J. – 2003. – Vol. 145. – P.248-253.

50.Almagor M. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease. / Keren A, Banai

121

S.// Am Heart J. – 2003. – Vol.145. – P.248-253.

51.Alvarez J. M., L. Chen, and I. N. Sinclair. Acute stent thrombosis after off-pump coronary bypass surgery: A new and avoidable complication? //J. Thorac. Cardiovasc. Surg.- - 2003.- Vol. 125(6).- P, 1544 - 1546.

52.Anderson HV, A contemporary overview of percutaneous coronary interventions. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR).// J Am Coll Cardiol.- 2002.-Vol. 39.-P. 1096-

53.Barakate MS, Hemli JM, Hughes CF, Bannon PG, Horton MD. Coronary artery bypass grafting (CABG) after initially successful percutaneous transluminal coronary angioplasty (PTCA): a review of 17 years experience.//

Eur. J. Cardiothorac. Surg -.2003.-Vol. 23(2).-P.179–186.

54.Barakate MS, Hemli JM, Hughes CF, Bannon PG, Horton MD. Coronary artery bypass grafting after initially successful percutaneous transluminal coronary angioplasty: a review of 17 years experience. //Eur J Cardiothorac Surg.- 2003.- Vol. 23.- P.179-186.

55.Bavry A.A.,Kumbhant D.,Helton T.J., et al/ Late thrombosis of drageluting stens: A meta-analysis of randomizet clinical trials// Amer.J.Med.- 2006.- Vol.119.-P.1056-1061.

56.Berger PB. Clinical outcome of patients undergoing non-cardiac surgery in the two months following coronary stenting.// J Am Coll Cardiol .- 2003. – Vol. 42. – P. 234–240.

57.Bittl J.A. Reducing the Risk of Emergency Bypass Surgery for Failed Percutaneous Coronary Interventions.// J Am Coll Cardiol. – 2005. – Vol. 46. –

P. 2010-2012.

58.BJ Cardio Staff. Intervention: who to treat and how?// Br. J. Cardiol.

2010.-Vol. 17 (Suppl. 3).- P.S5–S8.

59.Bonaros N., Hennerbichler D., Friedrich G., Bonatti J., et al. Increased

122

mortality and perioperative complications in patients with previous elective percutaneous coronary interventions undergoing coronary artery bypass surgery.// J Thorac Cardiovasc Surg/- 2009.- Vol. 137.- P. 846-852.

60.Booth J, Clayton T, Pepper J et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery trial (SoS)// Circulation.- 2008.-V. 118(4). P. 381–388.

61.Byrne JG, Karavas AN, Gudbjartson T, Leacche M, Rawn JD, Couper GS, Rizzo RJ, Cohn LH, Aranki SF. Left anterior descending coronary endarterectomy: early and late results in 196 consecutive patients.// Ann Thorac Surg.- 2004. – Vol. 78. – P. 867–873.

62.CABRI Trial Participants. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularization Investigation).// Lancet. –

1995.- Vol.346. – P.1179-1184.

63.Caramori PR, Lima VC, Seidelin PH, Newton GE, Parker JD, Adelman AG. Long-term endothelial dysfunction after coronary artery stenting //J Am Coll Cardiol – 1999. – Vol.34. – P.1675-16793.

64.Caramori PR, Lima VC, Seidelin PH, Newton GE, Parker JD, Adelman AG. Long-term endothelial dysfunction after coronary artery stenting //J Am Coll Cardiol. – 1999. – Vol.34. – P.1675-1679.

65.Casella G, Ottani F, Pavesi PC, et al. Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated metaanalysis.// Ital Heart J.- 2003.-Vol. 4.-P. 677–84.

66.Chew DP. Incremental prognostic value of elevated baseline C- reactive protein among established markers of risk in percutaneous coronary intervention./ Bhatt DL, Robbins MA, et al. // Circulation. – 2001. - -Vol.104.

– P. 992-997.

123

67.Chocron S, Baillot R, Rouleau JL et al. Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study.// Eur. Heart J. -2008.-Vol. 29(5).-P.673–679.

68.Chocron S., Baillot R., Rouleau J. L., et al. Impact of previous percutaneous transluminal coronary angioplasty and/or stenting revascularization on outcomes after surgical revascularization: insights from the imagine study.// European Heart Journal. -2008.- Vol. 29.- P. 673–679.

69.Cohn Lh, ed Coronary Artery Reoperations.. Cardiac Surgery in the Adult. New York: McGraw-Hill;- 2008. – P.711-732.

70.Coller BS, Anderson K, Weisman HF. New antiplatelet agents: platelet GPIIb/IIIa antagonists.// Thromb Haemost.- 1995.-Vol. 74.- P. 302–8.

71.Cutlip DE, Chhabra AG, Baim DS, Chauhan MS, Marulkar S, Massaro J, Bakhai A, Cohen DJ, Kuntz RE, Ho KKL. Beyond restenosis: five-year clinical outcomes from second-generation coronary stent trials//. Circulation - 2004. – Vol. 110 – P. 1226–1230.

72.Danenberg H. Systemic inflammation induced by lipopolysaccharide increases neointimal formation following balloon and stent injury in rabbits./ Welt F, Walker M, et al.// Circulation. – 2002. – Vol.105. – P.2917-2922.

73.Dibra A. et al. Inflammatory response after intervention assessed by serial C-reactive protein measurements correlates with restenosis in patients treated with coronary stenting. 2005.

74.Eifert S, Mair H, Boulesteix AL et al. Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG. //Vasc. Health Risk Manag. - 2010.- Vol. 6.- P.495–501.

75.F. Biancari1, G. Mariscalco2, A.S. Rubino3, G. Vinco4, F. Onorati5, G. Faggian5, T. Juvonen1, J. Airaksinen. The effect of prior percutaneous coronary

intervention on the immediate and late outcome after coronary artery bypass

124

grafting: systematic review and meta-analysis. //Heart, Lung and Vessels.-

2014.- In press.

76.Farb A, Weber DK, Kolodgie FD, Burke AP, Virmani R. Morphologic predictors of restenosis after coronary stenting in humans. //Circulation. - 2002. – Vol. 105 . – P.2974-2980.

77.Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angio-plasty in the treatment of coronary artery disease.// N Engl J Med.- 1994.-Vol. 331.-P.496–501.

78.Fukui T, Manabe S, Shimokawa T, Takanashi S. The Influence of Previous Percutaneous Coronary Intervention in Patients Undergoing OffPump Coronary Artery Bypass Grafting.// Ann Thorac Cardiovasc Surg.- 2010.- Vol. 16.- P. 99–104.

79.Fukui T, Takanashi S, Hosoda Y. Long segmental reconstruction of diffusely diseased left anterior descending coronary artery with left internal thoracic artery with or without endarterectomy. //Ann Thorac Surg. – 2005.- Vol. 80. - 2098–2105.

80.Gao G, Wu Y, Grunkemeier GL, Furnary AP, Starr A. Long-term survival of patients after coronary artery bypass graft surgery: comparison of the pre-stent and post-stent eras// Ann Thorac Surg. – 2006. – Vol. 82. – P. 806-810.

81.Gaspardone A. Predictive value of C-reactive protein after successful coronary artery stenting in patients with stable angina./ Crea F, Versaci F, et al. // Am J Cardiol. – 1998. – Vol. 82. – P.515-518.

82.Gaudino M, Cellini C, Pragliola C, et al. Arterial versus venous bypass grafts in patients with in-stent restenosis //Circulation. – 2005.- Vol. 112. – P. I265-I269.

83.Gaudino Mario. Patients With In-Stent Restenosis Have an Increased Risk of Mid-Term Venous Graft Failure. Nicola Luciani, Franco Glieca, Carlo

Cellini, Claudio Pragliola, Carlo Trani, Francesco Burzotta, Giovanni

125

Schiavoni, Amedeo Anselmi, and Gianfederico Possati //Ann Thorac Surg .-

2006. – Vol. 82. – P. 802-804.

84.Goa KL, Noble S. Eptifibatidea review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.//Drugs.- 1999.-Vol. 57.-P.439-462.

85.Gomes WJ, Buffolo E. Coronary stenting and inflammation: implications for further surgical and medical treatment.// Ann Thorac Surg –

2006. – Vol.81. – P.1918-1925.

86.Gomes WJ, Giannotti-Filho O, Paez RP, Hossne Jr NA, Catani R, Buffolo E. Coronary artery and myocardial inflammatory reaction induced by intracoronary stent //Ann Thorac Surg. – 2003. – Vol.76. – P.1528-1532.

87.Gottsauner-Wolf M. Plasma levels of C-reactive protein after coronary stent implantation./ Zasmeta G, Hornykewycz S, et al. // Eur Heart J.

– 2000 – Vol. 21. – P.1152-1158.

88.Grewe PH. Acute and chronic tissue response to coronary stent implantationpathologic findings in human specimen./ Deneke T, Machraoui A, et al. // J Am Coll Cardiol. – 2000. – V.35. – P.157-163.

89.Gurbuz AT, Zia AA, Cui H, Sasmazel A, Ates G, Aytac A. Predictors of mid-term symptom recurrence, adverse cardiac events and mortality in 591 unselected off-pump coronary artery bypass graft patients. //J Card Surg . –

2006. – Voil.21. – P.28-34.

90. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, Bennett E, et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. //N Engl J Med. - 2005. – Vol.352. – P.2174-2183.

91. Hannan EL, Racz MJ, Walford G et al. Long-term outcomes of coronary-artery bypass grafting versus stent implantation.// N. Engl. J. Med.

2005.-V. 352(21),-P. 2174–2183.

126

92. Hannan EL, Wu C, Walford G et al. Drug-eluting stents vs. coronaryartery bypass grafting in multivessel coronary disease //N. Engl. J. Med.-

2008.-V. 358(4)3- P. 31–341.

93.Hassan A, Buth KJ, Baskett RJ et al. The association between prior percutaneous coronary intervention and short-term outcomes after coronary artery bypass grafting.// Am. Heart J.- 2005.- Vol.-150(5).- P.1026–1031.

94.Herrmann J, Lerman A, Baumgart D, Volbracht L, Schulz R, von Birgelen C, et al. Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction.// Circulation. – 2002. –

Vol.106. – P.2180-2183.

95.Hoffman SN, TenBrook JA Jr, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: oneto eight-year outcomes.// J Am Coll Cardiol. – 2003. – Vol.41. – P.1293–1304.

96.Hoffman SN, TenBrook JA, Wolf MP, Pauker SG, Salem DN, Wong JB. A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: oneto eight-year outcomes.// J. Am. Coll. Cardiol. -2003.- Vol. 41(8).- P.1293–1304.

97.Hofma SH. Increasing arterial wall injury after long-term implantation of two types of stent in a porcine coronary model./ Whelan DM, van Beusekom HM, Verdouw PD, van der Giessen WJ.// Eur Heart J. – 1998. –

V.19. – P.601-609.

98. Hofma SH. Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries./ Whelan DM, van Beusekom HM, et al.// J Am Coll Cardiol. – 1998. – Vol.32.

– P.1109-1117.

99. Hojo Y. Release of endothelin 1 and angiotensin II induced by percutaneous transluminal coronary angioplasty./ Ikeda U, Katsuki T, et al.//

127

Catheter Cardiovasc Interv. – 2000. – Vol.51. – P.42-49.

100.Iakovou I, Schmidt T, Bonizzoni E, Lei G, Sangiorgi G, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.// JAMA - 2005. – Vol.293. – P.21262130.

101.Inoue K. Pathological analyses of long-term intracoronary Palmaz–

Schatz stenting. Is its efficacy permanent? / Abe K, Ando K, et al. // Cardiovasc Pathol. – 2004. – Vol.13. – P.109-113.

102. Janero DR. Nitric oxide and postangioplasty restenosispathological correlates and therapeutic potential./ Ewing JF. // Free Radical Bio Med 2000.

– V.29.- P.1199-1221.

103. Janero DR. Nitric oxide and postangioplasty restenosispathological correlates and therapeutic potential./ Ewing JF. // Free Radical Bio Med. – 2000. – Vol.29. – P.1199-1221.

104.Jarvis B, Simpson K. Clopidogrel: a review of its use in the prevention of atherothrombosis//. Drugs.- 2000.-Vol .60.- P. 347–77.

105.Javaid A et al. Does creatinine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome?. 2007.

106.Kamiya H., Ushhijima T, Mukai K, Ikeda C, Ueyama K, Watanbe G. Late patency of the internal thoracic artery graft in patients with and without previous successful percutaneous transluminal coronary angioplasty.//Interactive CardioVasc Thorac Surg. - 2004. – Vol.3. – P.110-

107.Gaszewska – Zurek E., Zurek P., Kazmierski M., Kargul T., et al. Coronary artery bypass grafting in patients withrelatively recent previous stent implantation:Three years follow-up result: Cardiology Journal. –

2009. – Vol. 16., N.4. – P. 312-316/

108.Kappetein A.P., Feldman T.E., Mack M.J., et al. Comparison of

128

coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial.// Eur Heart J.- 2011.- Vol.32(17).-.P.2125-2134.

109. Гланц C. Медико-биологическая статистика. Электронная книга = Primer of BIOSTATISTICS. — 4-е изд. — М.: Практика,

1999. — С. 459.

110.Kastrati A., Dibra A., Eberie S., et al. Sirolimus-eluting stents vs Politaxel-eluting stents in patients with coronary artery disease. Meta-analysis of randomized trials// JAMA.-2005.-Vol.294. –P.819-825

111.Kettelkamp R, House J, Garg M, Stuart RS, Grantham A, Spertus J. Using the risk of restenosis as a guide to triaging patients between surgical and percutaneous coronary revascularization//. Circulation – 2004. –

Vol.110(Suppl. 1). – P.II50–II54.

112. Kimura T. Long-term clinical and angiographic follow-up after coronary stent placement in native coronary arteries./ Abe K, Shizuta S, Odashiro K, Yoshida Y, Sakai K.// Circulation. – 2002. – Vol.105. – PO.2986-2991.

113. Lanka V., Patel V.G., Saeed B., Kotsia A. Christopoulos G., Rangan B.V., Mohammad A., Luna M., Garcia S., Abdullah S.M., Grodin J., Hastings J.L. Banerjee S., Brilakis E.S. Outcomes With FirstVersus SecondGeneration Drug-Eluting Stents in Coronary Chronic Total Occlusions (CTOs): A Systematic Review and Meta-Analysis.// J INVASIVE CARDIOL.-. 2014. – Vol. 26(7).- P.304-310

114.Lee S.G., C.W., С.W. Lee, M.K.Hong, H.K.Park, J.J.Kim, S.W.Park, S.J.Park. Predictors of diffuse-type in stent restenosis after coronary stent implantation // Catheter. Cardiovasc. Interv. – Vol.47. – 1999. – P. 406-409.

115.Libby P. Inflammation and atherosclerosis. / Ridker PM, Maseri A. // Circulation. – 2002 – Vol.105 – P.1135-1143.

129

116.Lisboa LA, Mejia OA, Dallan LA et al. Previous percutaneous coronary intervention as risk factor for coronary artery bypass grafting. //Arq. Bras. Cardiol. - 2012.- Vol.99(1).- P.586–595.

117.Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caliguri G, Vitelli A, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina.// Circulation – 1998, - Vol.98 .- P. 2370-2376.

118.Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC,

Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. //Circulation. – 2007. – Vol.115.- P.1051–1058.

119.Malenka DJ, Leavitt BJ, Hearne MJ et al. Comparing long-term survival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England.// Circulation.- 2005.- V. 112 (Suppl. 9).- P. I371–I376.

120.Mannacio V, Di Tommaso L, De Amicis V et al. Previous percutaneous coronary interventions increase mortality and morbidity after coronary surgery.// Ann. Thorac. Surg. -2012.- Vol. 93(6).- P.1956–1962.

121.Massoudy P, Thielmann M, Lehmann N et al. Impact of prior percutaneous coronary intervention on the outcome of coronary artery bypass surgery: a multicenter analysis.// J. Thorac. Cardiovasc. Surg. - 2009.- Vol. 137(4). - P.840–845.

122.Mehran R, Dangas GD, Kobayashi Y, Lansky AJ, Mintz GS, Aymong ED, Fahy M, Moses JW, Stone GW, Leon MB. Shortand long-term results after multivessel stenting in diabetic patients.// J Am Coll Cardiol. – 2004 –

Vol. 43. – P. 1348–1354.

123. Mercado N, Wijns W, Serruys PW et al. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual

130